Patent ID: 11918600
Assignee: SUZHOU RIBO LIFE SCIENCE CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 2:
3. The siRNA according to claim 2, wherein the nucleotide sequence 3 and the nucleotide sequence 4 both have a length of 1 nucleotide and the base of the nucleotide sequence 3 is G; or
the nucleotide sequence 3 and the nucleotide sequence 4 both have a length of 2 nucleotides; in the direction from 5′ terminal to 3′ terminal, the bases of the nucleotide sequence 3 are U and G in succession; or
the nucleotide sequence 3 and the nucleotide sequence 4 both have a length of 3 nucleotides; in the direction from 5′ terminal to 3′ terminal, the bases of the nucleotide sequence 3 are U, U and G in succession; or
the nucleotide sequence 3 and the nucleotide sequence 4 both have a length of 4 nucleotides; in the direction from 5′ terminal to 3′ terminal, the bases of the nucleotide sequence 3 are A, U, U, and G in succession.